Since 2010 when Burkina Faso had one of the highest rates of meningitis in the world, Men A meningitis has become less of a burden there. That’s when MenAfriVac, a new vaccine against MenA meningitis, was introduced to the citizens of Burkina Faso and other sub-Saharan African countries. MenAfriVac is designed specifically for Africa and is produced and administered at a low price, making it affordable for mass usage.

Photos: ©Evelyn Hockstein/CDC Foundation
7 photos · 91 views